Search Tag: Gustavo Pesquin
2023 10 Mar
Asklepios BioPharmaceutical, Inc., a wholly owned and independently operated subsidiary of Bayer AG announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (CEO) as of March 11, 2023. Pesquin joins AskBio from Amneal Pharmaceuticals, Inc., where he served as Chief Commercial Officer. Sheila Mikhail, Co-Founder and...Read more